Pharmaceuticals

sslld1.JPG

CD Targeted Bispecific Antibody Market Size, Share & Trends Analysis Report By Target Type (CD3, CD19 and CD30/CD16A), Region And Segment Forecasts, 2025-2034.

CD Targeted Bispecific Antibody Market is expected at an 14.5% CAGR during the forecast period for 2025-2034. InsightAce Analytic’s “Global CD Targeted Bispecific Antibody Market Research Report 2023” is a comprehensive analysis,...

Peptide_Cancer_Vaccine_Market.JPG

Peptide Cancer Vaccine Market Size, Share & Trends Analysis By Type (Multivalent Peptide Vaccine, Personalized Peptide Vaccine, Peptide Cocktail Type, Hybrid Peptide Vaccine, Peptide-Pulsed Dendritic Cancer Vaccine), By Application (Breast Cancer, Prostate Cancer, Lung Cancer, Melanoma), by Region, And by Segment Forecasts, 2025-2034.

Peptide Cancer Vaccine Market Size is valued at USD 1.6 Bn in 2024 and is predicted to reach USD 13.9 Bn by the year 2034 at a 24.5% CAGR during the forecast period for 2025-2034. Peptide cancer vaccines utilize tumour-derived peptides that stimul...

slld49.JPG

Infliximab Biosimilar Market Size, Share & Trends Analysis Report By Brand, Applications (Crohn’s disease, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, ankylosing spondylitis, plaque psoriasis, and others), Distribution Channel, Region And Segment Forecasts, 2025-2034

Infliximab Biosimilar Market Size is valued at XX Million in 2024 and is predicted to reach XX Million by the year 2034 at an XX % CAGR during the forecast period for 2025-2034. Infliximab is chimeric anti-TNF monoclonal antibody approved for the tr...

ssllld.JPG

Filgrastim Biosimilars Market Size, Share & Trends Analysis Report By Application (Febrile Neutropenia, Genital Neutropenia, Idiopathic Neutropenia, and Others), By Distribution Channel (Online Pharmacy, Hospital Pharmacy, and Retail Pharmacy), Region And Segment Forecasts, 2023-2031

Filgrastim Biosimilars Market Size is predicted to expand with a 8.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Governments around the world are promoting the use of biosimilars through...

slld26.JPG

Trastuzumab Biosimilar Market Size, Share & Trends Analysis Report By Product (Ogivri, Herzuma, Ontruzant, Trazimera, Other Pipeline Products), By Indication, By Route of Administration, By Molecule Type, Region And Segment Forecasts, 2025-2034

Trastuzumab Biosimilar Market is expected to grow at a 25.0 % CAGR during the forecast period for 2025-2034. Trastuzumab is a recombinant DNA-derived humanized monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2). HER2...

sld35.JPG

Oncolytic Virus Therapy Market Size, Share & Trends Analysis Report By Product (Herpes Simplex Virus (HSV), Adenoviruses, Vaccinia Virus, Vesicular Stomatitis Virus, Newcastle Disease Virus), By Application, By Region, And By Segment Forecasts, 2025-2034

Oncolytic Virus Therapy Market is estimated to grow at a 24.5% CAGR during the forecast period for 2025-2034. In recent decades, the healthcare burden of Cancer increasing rapidly with an increasing incidence rate. The massive investment in resear...